Author response for "Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined <scp>sodium‐glucose cotransporter‐2</scp> inhibitor and <scp>glucagon‐like peptide</scp>‐1 receptor agonist treatment in patients with type 2 diabetes and <scp>chronic kidney disease</scp>"